Please find the session links next to their corresponding agenda item.
Wednesday, June 9
Sponsor
12:00–12:05 PM
FDLI Welcome and Announcements
Laura A. Brown, Director, Educational Programs, FDLI
Enter this session: https://fdli.zoom.us/j/92782742167
12:05–12:50 PM
Featured Speaker
Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Enter this session: https://fdli.zoom.us/j/92782742167
1:05–2:05 PM
Regulation of Gene and Cell Therapy Manufacturing
Mo Heidaran, Vice President, Technical, Parexel International
Lawrence Starke, Global Regulatory Affairs (CMC) Policy and Intelligence, Cell & Gene Therapy, Novartis Pharmaceutical Company
Moderated by Kathleen M. Sanzo, Partner, Morgan, Lewis & Bockius LLP
Enter this session: https://fdli.zoom.us/j/95719779707
2:05–2:35 PM
Break
2:35–3:20 PM
Ensuring Regenerative Therapy Product Compliance with FDA
Allison Fulton, Partner, Sheppard Mullin Richter & Hampton LLP
Melissa Mendoza, Deputy Director, Office of Compliance and Biologics Quality, CBER, FDA
Moderated by Kalah Auchincloss, SVP and Deputy General Counsel, Greenleaf Health, Inc.
Enter this session: https://fdli.zoom.us/j/95183522872
3:35 – 4:20 PM
Gene and Cell Therapy Coverage, Reimbursement, and Pricing
Rochelle Fink, Senior Health Science Project Manager, CDRH, FDA
Michael Werner, Partner, Holland & Knight LLP
Moderated by Catherine A. Brandon, Partner, Arnold & Porter LLP
Enter this session: https://fdli.zoom.us/j/92447670248
4:20 PM
Closing Remarks and Adjournment